Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer

NCT00347412 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

903

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Paclitaxel
DRUG: NOV-002
DRUG: Carboplatin

Sponsor

Cellectar Biosciences, Inc.